Cargando…

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials

The ability to accurately estimate the sample size required by a stepped‐wedge (SW) cluster randomized trial (CRT) routinely depends upon the specification of several nuisance parameters. If these parameters are misspecified, the trial could be overpowered, leading to increased cost, or underpowered...

Descripción completa

Detalles Bibliográficos
Autores principales: Grayling, Michael J., Mander, Adrian P., Wason, James M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175439/
https://www.ncbi.nlm.nih.gov/pubmed/30073685
http://dx.doi.org/10.1002/bimj.201700125
_version_ 1783361512922939392
author Grayling, Michael J.
Mander, Adrian P.
Wason, James M. S.
author_facet Grayling, Michael J.
Mander, Adrian P.
Wason, James M. S.
author_sort Grayling, Michael J.
collection PubMed
description The ability to accurately estimate the sample size required by a stepped‐wedge (SW) cluster randomized trial (CRT) routinely depends upon the specification of several nuisance parameters. If these parameters are misspecified, the trial could be overpowered, leading to increased cost, or underpowered, enhancing the likelihood of a false negative. We address this issue here for cross‐sectional SW‐CRTs, analyzed with a particular linear‐mixed model, by proposing methods for blinded and unblinded sample size reestimation (SSRE). First, blinded estimators for the variance parameters of a SW‐CRT analyzed using the Hussey and Hughes model are derived. Following this, procedures for blinded and unblinded SSRE after any time period in a SW‐CRT are detailed. The performance of these procedures is then examined and contrasted using two example trial design scenarios. We find that if the two key variance parameters were underspecified by 50%, the SSRE procedures were able to increase power over the conventional SW‐CRT design by up to 41%, resulting in an empirical power above the desired level. Thus, though there are practical issues to consider, the performance of the procedures means researchers should consider incorporating SSRE in to future SW‐CRTs.
format Online
Article
Text
id pubmed-6175439
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61754392018-10-19 Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials Grayling, Michael J. Mander, Adrian P. Wason, James M. S. Biom J Issues in Complex Clinical Trials The ability to accurately estimate the sample size required by a stepped‐wedge (SW) cluster randomized trial (CRT) routinely depends upon the specification of several nuisance parameters. If these parameters are misspecified, the trial could be overpowered, leading to increased cost, or underpowered, enhancing the likelihood of a false negative. We address this issue here for cross‐sectional SW‐CRTs, analyzed with a particular linear‐mixed model, by proposing methods for blinded and unblinded sample size reestimation (SSRE). First, blinded estimators for the variance parameters of a SW‐CRT analyzed using the Hussey and Hughes model are derived. Following this, procedures for blinded and unblinded SSRE after any time period in a SW‐CRT are detailed. The performance of these procedures is then examined and contrasted using two example trial design scenarios. We find that if the two key variance parameters were underspecified by 50%, the SSRE procedures were able to increase power over the conventional SW‐CRT design by up to 41%, resulting in an empirical power above the desired level. Thus, though there are practical issues to consider, the performance of the procedures means researchers should consider incorporating SSRE in to future SW‐CRTs. John Wiley and Sons Inc. 2018-08-03 2018-09 /pmc/articles/PMC6175439/ /pubmed/30073685 http://dx.doi.org/10.1002/bimj.201700125 Text en © 2018 The Authors. Biometrical Journal Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Issues in Complex Clinical Trials
Grayling, Michael J.
Mander, Adrian P.
Wason, James M. S.
Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
title Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
title_full Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
title_fullStr Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
title_full_unstemmed Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
title_short Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
title_sort blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
topic Issues in Complex Clinical Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175439/
https://www.ncbi.nlm.nih.gov/pubmed/30073685
http://dx.doi.org/10.1002/bimj.201700125
work_keys_str_mv AT graylingmichaelj blindedandunblindedsamplesizereestimationproceduresforsteppedwedgeclusterrandomizedtrials
AT manderadrianp blindedandunblindedsamplesizereestimationproceduresforsteppedwedgeclusterrandomizedtrials
AT wasonjamesms blindedandunblindedsamplesizereestimationproceduresforsteppedwedgeclusterrandomizedtrials